238 related articles for article (PubMed ID: 16842844)
1. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
3. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
4. Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding.
Sonoda K; Miyamoto S; Nakashima M; Wake N
Exp Cell Res; 2010 Jul; 316(11):1795-803. PubMed ID: 20079734
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
[TBL] [Abstract][Full Text] [Related]
6. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
[TBL] [Abstract][Full Text] [Related]
7. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.
Sonoda K; Miyamoto S; Yamazaki A; Kobayashi H; Nakashima M; Mekada E; Wake N
Cancer; 2007 Nov; 110(9):1979-90. PubMed ID: 17849467
[TBL] [Abstract][Full Text] [Related]
8. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
9. [Histologic diagnosis of endometrial cancer].
Kaku T; Kawano Y; Hagiwara T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
[No Abstract] [Full Text] [Related]
10. Invasive potency related to RCAS1 expression in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Oct; 99(1):189-98. PubMed ID: 16112176
[TBL] [Abstract][Full Text] [Related]
11. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
12. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
13. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
14. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
15. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma].
Wu HW; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346
[No Abstract] [Full Text] [Related]
16. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
[TBL] [Abstract][Full Text] [Related]
17. Serum tissue polypeptide specific antigen (TPS) in patients with cervical carcinoma: preliminary report.
Pattaranutaporn P; Chansilpa Y; Tangkarat S; Tepmongkol P; Sangruchi S; Senapad S
Anticancer Res; 1997; 17(3C):2309-12. PubMed ID: 9216707
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
Pylväs M; Puistola U; Laatio L; Kauppila S; Karihtala P
Anticancer Res; 2011 Apr; 31(4):1411-5. PubMed ID: 21508394
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of RCAS1 as serum tumor marker for pancreatic cancer].
Yang YC; Zhao YP; Liao Q; Zhang TP; Hu Y; Dai MH
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):999-1001. PubMed ID: 19957811
[TBL] [Abstract][Full Text] [Related]
20. The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas.
Dutsch-Wicherek M; Wicherek L
Am J Reprod Immunol; 2008 Mar; 59(3):266-75. PubMed ID: 18275520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
